BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $4.87 million. The enterprise value is $1.49 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BGLC has 1.80 million shares outstanding. The number of shares has increased by 7.32% in one year.
| Current Share Class | 1.80M |
| Shares Outstanding | 1.80M |
| Shares Change (YoY) | +7.32% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 30.98% |
| Owned by Institutions (%) | 0.88% |
| Float | 1.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| Forward PS | n/a |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.19 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -108.47 |
Financial Efficiency
Return on equity (ROE) is -24.75% and return on invested capital (ROIC) is -16.58%.
| Return on Equity (ROE) | -24.75% |
| Return on Assets (ROA) | -14.05% |
| Return on Invested Capital (ROIC) | -16.58% |
| Return on Capital Employed (ROCE) | -29.30% |
| Revenue Per Employee | $308,862 |
| Profits Per Employee | -$70,597 |
| Employee Count | 30 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 7.09 |
Taxes
| Income Tax | -16,574 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.49% in the last 52 weeks. The beta is 1.91, so BGLC's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -44.49% |
| 50-Day Moving Average | 2.96 |
| 200-Day Moving Average | 3.30 |
| Relative Strength Index (RSI) | 43.92 |
| Average Volume (20 Days) | 69,709 |
Short Selling Information
The latest short interest is 15,897, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 15,897 |
| Short Previous Month | 61,651 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, BGLC had revenue of $9.27 million and -$2.12 million in losses. Loss per share was -$1.18.
| Revenue | 9.27M |
| Gross Profit | 1.27M |
| Operating Income | -2.32M |
| Pretax Income | -2.64M |
| Net Income | -2.12M |
| EBITDA | -2.21M |
| EBIT | -2.32M |
| Loss Per Share | -$1.18 |
Full Income StatementBalance Sheet
The company has $3.60 million in cash and $216,427 in debt, giving a net cash position of $3.38 million or $1.88 per share.
| Cash & Cash Equivalents | 3.60M |
| Total Debt | 216,427 |
| Net Cash | 3.38M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 7.77M |
| Book Value Per Share | 4.33 |
| Working Capital | 4.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.02 million and capital expenditures -$214,096, giving a free cash flow of -$3.24 million.
| Operating Cash Flow | -3.02M |
| Capital Expenditures | -214,096 |
| Free Cash Flow | -3.24M |
| FCF Per Share | -$1.80 |
Full Cash Flow StatementMargins
Gross margin is 13.68%, with operating and profit margins of -25.05% and -22.86%.
| Gross Margin | 13.68% |
| Operating Margin | -25.05% |
| Pretax Margin | -23.04% |
| Profit Margin | -22.86% |
| EBITDA Margin | -23.85% |
| EBIT Margin | -25.05% |
| FCF Margin | n/a |
Dividends & Yields
BGLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.32% |
| Shareholder Yield | -7.32% |
| Earnings Yield | -43.50% |
| FCF Yield | -66.45% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2025. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Apr 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
BGLC has an Altman Z-Score of 2.85 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 1 |